NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ:OPHT) announced today that the Company will host a live webcast in conjunction with its Research and Development (R&D) Investor Day on Thursday, December 3, 2015, beginning at 8:30 a.m. ET. Ophthotech’s management will provide an overview of the Company’s Fovista® (pegpleranib) programs in the current treatment paradigm of wet age-related macular degeneration. The Company will host a panel discussion with a leading group of retina specialists.
